Balyasny Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-288,612
| Closed | -$1.08M | – | 2289 |
|
2024
Q1 | $1.08M | Buy |
+288,612
| New | +$1.08M | ﹤0.01% | 1238 |
|
2023
Q4 | – | Sell |
-326,770
| Closed | -$2.73M | – | 2178 |
|
2023
Q3 | $2.73M | Buy |
+326,770
| New | +$2.73M | 0.01% | 924 |
|
2023
Q1 | – | Sell |
-349,391
| Closed | -$2.86M | – | 2518 |
|
2022
Q4 | $2.86M | Buy |
+349,391
| New | +$2.86M | 0.01% | 929 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 2654 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 2591 |
|
2022
Q1 | – | Sell |
-26,309
| Closed | -$538K | – | 2400 |
|
2021
Q4 | $538K | Buy |
+26,309
| New | +$538K | ﹤0.01% | 1381 |
|
2020
Q3 | – | Sell |
-19,029
| Closed | -$66K | – | 1276 |
|
2020
Q2 | $66K | Buy |
+19,029
| New | +$66K | ﹤0.01% | 901 |
|
2019
Q4 | – | Sell |
-651,043
| Closed | -$3.36M | – | 1262 |
|
2019
Q3 | $3.36M | Sell |
651,043
-38,237
| -6% | -$197K | 0.02% | 539 |
|
2019
Q2 | $4.17M | Sell |
689,280
-749,776
| -52% | -$4.54M | 0.03% | 563 |
|
2019
Q1 | $10.4M | Buy |
1,439,056
+1,402,467
| +3,833% | +$10.1M | 0.07% | 333 |
|
2018
Q4 | $271K | Sell |
36,589
-436,767
| -92% | -$3.23M | ﹤0.01% | 1147 |
|
2018
Q3 | $2.56M | Buy |
+473,356
| New | +$2.56M | 0.01% | 720 |
|
2018
Q2 | – | Sell |
-19,958
| Closed | -$41K | – | 1833 |
|
2018
Q1 | $41K | Buy |
19,958
+662
| +3% | +$1.36K | ﹤0.01% | 1677 |
|
2017
Q4 | $51K | Sell |
19,296
-14,204
| -42% | -$37.5K | ﹤0.01% | 1765 |
|
2017
Q3 | $176K | Buy |
+33,500
| New | +$176K | ﹤0.01% | 1518 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 1250 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 1062 |
|
2016
Q2 | – | Sell |
-11,100
| Closed | -$94K | – | 1166 |
|
2016
Q1 | $94K | Sell |
11,100
-244,556
| -96% | -$2.07M | ﹤0.01% | 1002 |
|
2015
Q4 | $3.36M | Buy |
+255,656
| New | +$3.36M | 0.02% | 489 |
|